Risk Factor Control Five Years after Coronary Bypass Grafting
暂无分享,去创建一个
M. Farrer | C. Albers | P. Adams | J. Skinner
[1] H. Daida,et al. Relation of saphenous vein graft obstruction to serum cholesterol levels. , 1995, Journal of the American College of Cardiology.
[2] Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) , 1994, The Lancet.
[3] M. Buchalter,et al. Inadequate management of hyperlipidaemia after coronary bypass surgery shown by medical audit. , 1994, British heart journal.
[4] J. Simons,et al. Coronary risk factors 6‐12 months after coronary artery bypass grafting: Comparison of surveys in 1986, 1990 and 1994 , 1994, The Medical journal of Australia.
[5] G. Bondjers,et al. Serum triglycerides and HDL cholesterol--major predictors of long-term survival after coronary surgery. , 1994, European heart journal.
[6] D. Betteridge,et al. Management of hyperlipidaemia: guidelines of the British Hyperlipidaemia Association. , 1993, Postgraduate medical journal.
[7] C. Bulpitt,et al. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. , 1993, BMJ.
[8] R H Jones,et al. Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery. , 1991, Circulation.
[9] S. Azen,et al. Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up. , 1990, JAMA.
[10] W. Roberts. Recent studies on the effects of beta blockers on blood lipid levels. , 1989, American heart journal.
[11] D H Blankenhorn,et al. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. , 1987, JAMA.
[12] S. Wacholder,et al. The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery. , 1984, The New England journal of medicine.
[13] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.
[14] B. Gersh,et al. Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the Coronary Artery Surgery Study (CASS): 10-year follow-up. CASS Investigators. , 1992, Journal of the American College of Cardiology.
[15] G. Lawrie,et al. Long-term results of coronary bypass surgery. Analysis of 1698 patients followed 15 to 20 years. , 1991, Annals of surgery.
[16] R. Hoffmann,et al. Risk factors among patients undergoing repeat aorta-coronary bypass procedures. , 1987, The Journal of thoracic and cardiovascular surgery.